FDA Issues Guidance on AI Improving Health Care
Per the notice below, the United States Food and Drug Administration (FDA) has issued guidance on how artificial intelligence (AI) can be used to improve health care.
New Blog: The Promise of Artificial Intelligence for Improving Health Care
Artificial intelligence (AI) is rapidly changing the health care industry and holds transformative potential, writes Troy Tazbaz, Director, Digital Health Center of Excellence (DHCoE), Center for Devices and Radiological Health, U.S. Food and Drug Administration, in a new blog post. Among the possibilities AI offers are:
At the FDA, we know that the proper integration of AI across the health care ecosystem will be paramount to achieving its potential while reducing risks and challenges. |